We are live on ! Find out more
EIM

Essex Investment Management Portfolio holdings

AUM $632M
1-Year Est. Return 95.36%
This Fund
S&P 500
This Quarter Est. Return
+16.88%
1 Year Est. Return
+95.36%
3 Year Est. Return
+271.62%
5 Year Est. Return
+354.98%
10 Year Est. Return
+3,586.14%
AUM
$820M
AUM Growth
+$14.5M
Cap. Flow
-$58.3M
Cap. Flow %
-7.11%
Top 10 Hldgs %
15.04%
Holding
537
New
56
Increased
73
Reduced
203
Closed
92

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$6.12M
2
CRSP icon
CRISPR Therapeutics
CRSP
+$5.37M
3
ST icon
Sensata Technologies
ST
+$5.01M
4
DRIO icon
DarioHealth
DRIO
+$3.05M
5
TWTR
Twitter, Inc.
TWTR
+$3.05M

Sector Composition

Rank Sector Weight
1 Technology 24.55%
2 Healthcare 17.09%
3 Industrials 12.67%
4 Materials 10.49%
5 Consumer Discretionary 9.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
USB icon
426
US Bancorp
USB
$101B
$8K ﹤0.01%
150
EMR icon
427
Emerson Electric
EMR
$89.7B
$7K ﹤0.01%
73
MDLZ icon
428
Mondelez International
MDLZ
$80.8B
$7K ﹤0.01%
127
CIM
429
Chimera Investment
CIM
$1B
$6K ﹤0.01%
159
HXL icon
430
Hexcel
HXL
$7.64B
$6K ﹤0.01%
99
LIN icon
431
Linde
LIN
$222B
$6K ﹤0.01%
20
TYG
432
Tortoise Energy Infrastructure Corp
TYG
$1.1B
$5K ﹤0.01%
220
+2
+0.9% +$47
BNY
433
Bank of New York Mellon
BNY
$110B
$4K ﹤0.01%
84
BR icon
434
Broadridge
BR
$19.2B
$3K ﹤0.01%
18
ENB icon
435
Enbridge
ENB
$112B
$3K ﹤0.01%
85
LYB icon
436
LyondellBasell Industries
LYB
$20.2B
$3K ﹤0.01%
25
CHX
437
DELISTED
ChampionX
CHX
$2K ﹤0.01%
78
GMLP
438
DELISTED
Golar LNG Partners LP
GMLP
$1K ﹤0.01%
184
ACAD icon
439
Acadia Pharmaceuticals
ACAD
$5B
-19,135
Closed -$1.02M
ADBE icon
440
Adobe
ADBE
$102B
-3,827
Closed -$1.91M
ADMA icon
441
ADMA Biologics
ADMA
$2.1B
-627,931
Closed -$1.22M
AIRG icon
442
Airgain
AIRG
$70.2M
-90,235
Closed -$1.6M
AKAM icon
443
Akamai
AKAM
$17.9B
-12,539
Closed -$1.32M
ALLT icon
444
Allot
ALLT
$381M
-134,442
Closed -$1.41M
AMD icon
445
Advanced Micro Devices
AMD
$802B
-20,000
Closed -$1.83M
AMSC icon
446
American Superconductor
AMSC
$1.55B
-161,994
Closed -$3.79M
ARRY icon
447
Array Technologies
ARRY
$798M
-93,788
Closed -$4.05M
BDX icon
448
Becton Dickinson
BDX
$50.1B
-1,967
Closed -$480K
BGS icon
449
B&G Foods
BGS
$297M
-36,092
Closed -$1M
BHC icon
450
Bausch Health
BHC
$2.35B
-38,973
Closed -$811K

Similar funds

Essex Investment Management's Q1 2021 Portfolio in Review

As of Q1 2021, Essex Investment Management held 537 positions worth $820M, up 1.8% from $806M the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Essex Investment Management withdrew a net $58.3M in Q1 2021, closing 92 positions and reducing 203 holdings. Its most notable exit was VeriSign, an estimated $5.32M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Essex Investment Management opened a new position in CRISPR Therapeutics worth $4.33M.

  • Essex Investment Management's largest Q1 2021 buy was CRISPR Therapeutics: 35,540 shares worth $4.33M.
  • Essex Investment Management added most to AT&T in Q1 2021, an estimated $6.12M increase.
  • Essex Investment Management's biggest Q1 2021 reduction was Teladoc Health, cutting an estimated $8.61M.
  • Essex Investment Management fully exited VeriSign in Q1 2021, selling an estimated $5.32M.
  • Essex Investment Management's ten largest holdings make up 15% of its $820M portfolio in Q1 2021.
  • Essex Investment Management opened 56 new positions and closed 92 in Q1 2021.
  • Essex Investment Management's portfolio value rose 1.8% quarter-over-quarter to $820M.

Based on Essex Investment Management's 13F filing for Q1 2021, filed 12 May 2021.